Literature DB >> 27162243

Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT.

Pietro Crivello1, Andreas Heinold2, Vera Rebmann2, Hellmut D Ottinger3, Peter A Horn4, Dietrich W Beelen3, Katharina Fleischhauer5.   

Abstract

The role of HLA amino acid (AA) polymorphism for the outcome of hematopoietic cell transplantation (HCT) is controversial, in particular for HLA class II. Here, we investigated this question in nonpermissive HLA-DPB1 T-cell epitope (TCE) mismatches reflected by numerical functional distance (FD) scores, assignable to all HLA-DPB1 alleles based on the combined impact of 12 polymorphic AAs. We calculated the difference in FD scores (ΔFD) of mismatched HLA-DPB1 alleles in patients and their 10/10 HLA-matched unrelated donors of 379 HCTs performed at our center for acute leukemia or myelodysplastic syndrome. Receiver-operator curve-based stratification into 2 ΔFD subgroups showed a significantly higher percentage of nonpermissive TCE mismatches for ΔFD >2.665, compared with ΔFD ≤2.665 (88% vs 25%, P < .0001). In multivariate analysis, ΔFD >2.665 was significantly associated with overall survival (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.05-1.87; P < .021) and event-free survival (HR, 1.39; 95% CI, 1.05-1.82; P < .021), compared with ΔFD ≤2.665. These associations were stronger than those observed for TCE mismatches. There was a marked but not statistically significant increase in the hazards of relapse and nonrelapse mortality in the high ΔFD subgroup, whereas no differences were observed for acute and chronic graft-versus-host disease. Seven nonconservative AA substitutions in peptide-binding positions had a significantly stronger impact on ΔFD compared with 5 others (P = .0025), demonstrating qualitative differences in the relative impact of AA polymorphism in HLA-DPB1. The novel concept of ΔFD sheds new light onto nonpermissive HLA-DPB1 mismatches in unrelated HCT.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27162243     DOI: 10.1182/blood-2015-12-686238

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection.

Authors:  Katharina Fleischhauer; Katharine C Hsu; Bronwen E Shaw
Journal:  Bone Marrow Transplant       Date:  2018-05-24       Impact factor: 5.483

Review 2.  In celebration of Ruggero Ceppellini: HLA in transplantation.

Authors:  E W Petersdorf
Journal:  HLA       Date:  2017-02       Impact factor: 4.513

3.  Predicting relevant immunogenetic disparities.

Authors:  Joseph Pidala; Claudio Anasetti
Journal:  Blood       Date:  2016-07-07       Impact factor: 22.113

4.  Comparative evaluation of biological human leukocyte antigen DPB1 mismatch models for survival and graft-versus-host disease prediction after unrelated donor hematopoietic cell transplantation.

Authors:  Francesca Lorentino; Nicoletta Sacchi; Elena Oldani; Valeria Miotti; Alessandra Picardi; Anna Maria Gallina; Pietro Crivello; Paolo Bernasconi; Riccardo Saccardi; Lucia Farina; Fabio Benedetti; Michela Cerno; Anna Grassi; Benedetto Bruno; Francesca Patriarca; Fabio Ciceri; Katharina Fleischhauer; Luca Vago; Francesca Bonifazi
Journal:  Haematologica       Date:  2019-08-30       Impact factor: 9.941

5.  Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.

Authors:  Jun Zou; Stefan O Ciurea; Piyanuch Kongtim; Min Yi; Yudith Carmazzi; Gabriela Rondon; Samer Srour; David Partlow; Richard E Champlin; Kai Cao
Journal:  Blood Adv       Date:  2020-08-11

6.  Selection of matched unrelated donors moving forward: from HLA allele counting to functional matching.

Authors:  Katharina Fleischhauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

7.  HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.

Authors:  T Yabe; F Azuma; K Kashiwase; K Matsumoto; T Orihara; H Yabe; S Kato; K Kato; S Kai; T Mori; S Morishima; M Satake; M Takanashi; K Nakajima; Y Morishima
Journal:  Leukemia       Date:  2017-06-27       Impact factor: 11.528

8.  Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.

Authors:  Effie W Petersdorf; Mats Bengtsson; Dianne De Santis; Valerie Dubois; Katharina Fleischhauer; Ted Gooley; Mary Horowitz; J Alejandro Madrigal; Mari Malkki; Caroline McKallor; Yasuo Morishima; Machteld Oudshoorn; Stephen R Spellman; Jean Villard; Phil Stevenson; Mary Carrington
Journal:  J Clin Oncol       Date:  2020-06-01       Impact factor: 44.544

9.  Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.

Authors:  K Fleischhauer; K W Ahn; H L Wang; L Zito; P Crivello; C Müller; M Verneris; B E Shaw; J Pidala; M Oudshorn; S J Lee; S R Spellman
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

10.  Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.

Authors:  Betül Oran; Rima M Saliba; Yudith Carmazzi; Marcos de Lima; Gabriela Rondon; Sairah Ahmed; Amin Alousi; Borje S Andersson; Paolo Anderlini; Michelle Alvarez; Qasier Bashir; Stefan Ciurea; Marcelo Fernandez-Vina; Chitra Hosing; Partow Kebriaei; Martin Korbling; Pedro Cano; Issa Khouri; David Marin; Yago Nieto; Amanda Olson; Uday Popat; Katy Rezvani; Muzaffar Qazilbash; Elizabeth J Shpall; Richard E Champlin; Kai Cao
Journal:  Blood       Date:  2018-01-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.